Viewing Study NCT05965102


Ignite Creation Date: 2025-12-25 @ 3:52 AM
Ignite Modification Date: 2025-12-26 @ 2:40 AM
Study NCT ID: NCT05965102
Status: UNKNOWN
Last Update Posted: 2023-07-28
First Post: 2023-04-23
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Tirellizumab Combined With Chemotherapy Monotherapy for Non-small Cell Lung Cancer
Sponsor: Second Affiliated Hospital of Guangzhou Medical University
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-08-01
Start Date Type: ESTIMATED
Primary Completion Date: 2025-04-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-06-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-04-23
First Submit QC Date: None
Study First Post Date: 2023-07-28
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-27
Last Update Post Date: 2023-07-28
Last Update Post Date Type: ACTUAL